发布求助
文献互助 智能选刊 最新文献

The Korean Journal of Helicobacter and Upper Gastrointestinal Research最新文献

筛选
英文 中文
Comparison of Helicobacter pylori Eradication Rates Using Standard Triple Therapy and Sequential Therapy 采用标准三联疗法和序贯疗法的幽门螺杆菌根除率比较
The Korean Journal of Helicobacter and Upper Gastrointestinal Research Pub Date : 2023-12-10 DOI: 10.7704/kjhugr.2023.0042
Yuria Kim, J. Ahn, H. Jung, J. Noh, H. Na, Kee Wook Jung, Jeong Hoon Lee, D. Kim, K. Choi, H. Song, G. Lee
{"title":"Comparison of Helicobacter pylori Eradication Rates Using Standard Triple Therapy and Sequential Therapy","authors":"Yuria Kim, J. Ahn, H. Jung, J. Noh, H. Na, Kee Wook Jung, Jeong Hoon Lee, D. Kim, K. Choi, H. Song, G. Lee","doi":"10.7704/kjhugr.2023.0042","DOIUrl":"https://doi.org/10.7704/kjhugr.2023.0042","url":null,"abstract":"Objectives: The incidence of treatment failures following standard triple therapy (STT) for Helicobacter pylori eradication (HPE) has reached an unacceptable level. Sequential therapy (SQ) has emerged as a promising approach to counteract the escalation of antibiotic resistance. In this study, we used a chronological cohort dataset to conduct a comparative analysis of the eradication rates, compliance, and adverse events associated with the 7-day STT and SQ.Methods: A total of 789 patients underwent HPE treatment at Asan Medical Center between July 2013 and August 2017. Among them, 378 received a 7-day STT and 411 received a 10-day SQ. Baseline clinical data and treatment parameters were compared between the two treatment groups.Results: SQ demonstrated an eradication rate of 84.7% (348/411), which was superior to that of the 7-day STT (74.1%; p<0.001). The incidence of adverse events was also higher in the SQ group than in the STT group (17.5% vs. 11.1%; p=0.01). Nonetheless, treatment compliance was not significantly different between the groups (98.1% [SQ] vs. 96.8% [STT]; p=0.38). Among the patients undergoing second-line eradication, the SQ group displayed a lower eradication rate than the STT group (77.8% vs. 92.4%; p=0.028). Notably, the overall eradication rate did not differ significantly between the two groups (98.3% [STT] vs. 97.4% [SQ]; p=0.56).Conclusions: SQ exhibited superior efficacy compared with the 7-day STT as a first-line H. pylori treatment. Thus, SQ holds potential to serve as the replacement for the 7-day STT in treatment-naïve patients.","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":"13 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138585300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Does Types of 23S-Ribosomal RNA Point Mutations Affect Helicobacter pylori Eradication Rate in Clarithromycin-Based Triple Therapy? 23S-Ribosomal RNA 点突变类型会影响克拉霉素三联疗法的幽门螺旋杆菌根除率吗？
The Korean Journal of Helicobacter and Upper Gastrointestinal Research Pub Date : 2023-12-10 DOI: 10.7704/kjhugr.2023.0062
Da Hyun Jung
{"title":"Does Types of 23S-Ribosomal RNA Point Mutations Affect Helicobacter pylori Eradication Rate in Clarithromycin-Based Triple Therapy?","authors":"Da Hyun Jung","doi":"10.7704/kjhugr.2023.0062","DOIUrl":"https://doi.org/10.7704/kjhugr.2023.0062","url":null,"abstract":"","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":"9 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138585111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Precision Medicine for Gastric Cancer: Applicability from the Perspective of Helicobacter pylori Infection 胃癌精准医疗:幽门螺杆菌感染视角下的适用性
The Korean Journal of Helicobacter and Upper Gastrointestinal Research Pub Date : 2023-09-15 DOI: 10.7704/kjhugr.2023.0030
Ah Cheon Park, Sung Eun Kim
{"title":"Precision Medicine for Gastric Cancer: Applicability from the Perspective of Helicobacter pylori Infection","authors":"Ah Cheon Park, Sung Eun Kim","doi":"10.7704/kjhugr.2023.0030","DOIUrl":"https://doi.org/10.7704/kjhugr.2023.0030","url":null,"abstract":"","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48139704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Possibility of Endoscopic Resection in Localized Gastric Mucosa-associated Lymphoid Tissue Lymphoma 内镜下切除胃黏膜相关淋巴组织淋巴瘤的可能性
The Korean Journal of Helicobacter and Upper Gastrointestinal Research Pub Date : 2023-09-15 DOI: 10.7704/kjhugr.2023.0033
Sun Hyung Kang
{"title":"Possibility of Endoscopic Resection in Localized Gastric Mucosa-associated Lymphoid Tissue Lymphoma","authors":"Sun Hyung Kang","doi":"10.7704/kjhugr.2023.0033","DOIUrl":"https://doi.org/10.7704/kjhugr.2023.0033","url":null,"abstract":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research is an Open-Access Journal. All articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (https:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. EDITORIAL ISSN 1738-3331 eISSN 2671-826X, https://doi.org/10.7704/kjhugr.2023.0033 Korean J Helicobacter Up Gastrointest Res, 2023;23(3):155-156","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48186859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dysphagia Secondary to Vocal Cord Paralysis: A Case Report 声带麻痹继发吞咽困难1例报告
The Korean Journal of Helicobacter and Upper Gastrointestinal Research Pub Date : 2023-09-15 DOI: 10.7704/kjhugr.2023.0031
Oong Hee Shin, J. Kim, B. Kim
{"title":"Dysphagia Secondary to Vocal Cord Paralysis: A Case Report","authors":"Oong Hee Shin, J. Kim, B. Kim","doi":"10.7704/kjhugr.2023.0031","DOIUrl":"https://doi.org/10.7704/kjhugr.2023.0031","url":null,"abstract":"A 51-year-old man with a 10-day history of acute-onset dysphagia presented with inability to swallow anything orally. The patient was unable to swallow any radiopaque contrast medium; therefore, a videofluoroscopic swallow study could not be performed. Brain imaging, neurological findings, and initial endoscopy findings were normal. Neck computed tomography suggested left vocal cord paralysis. The patient was diagnosed with diabetes one year prior to presentation but did not receive any treatment. Insulin therapy during hospitalization controlled the patient’s blood glucose levels, and his symptoms improved without any sequelae. We present a rare case of vocal cord paralysis secondary to controlled diabetes. The initial endoscopic examination did not include thorough evaluation of the vocal cords; therefore, accurate diagnosis was challenging in this case.","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47619183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastric Cancer of the Cardia Detected on Screening Endoscopy 内镜筛查贲门癌症
The Korean Journal of Helicobacter and Upper Gastrointestinal Research Pub Date : 2023-09-15 DOI: 10.7704/kjhugr.2023.0035
Seung Joo Kang
{"title":"Gastric Cancer of the Cardia Detected on Screening Endoscopy","authors":"Seung Joo Kang","doi":"10.7704/kjhugr.2023.0035","DOIUrl":"https://doi.org/10.7704/kjhugr.2023.0035","url":null,"abstract":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research is an Open-Access Journal. All articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (https:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. IMAGE OF THE ISSUE ISSN 1738-3331 eISSN 2671-826X, https://doi.org/10.7704/kjhugr.2023.0035 Korean J Helicobacter Up Gastrointest Res, 2023;23(3):225-227","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47925649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimal Use of Proton Pump Inhibitors and Potassium-competitive Acid Blockers 质子泵抑制剂和钾竞争酸阻滞剂的最佳使用
The Korean Journal of Helicobacter and Upper Gastrointestinal Research Pub Date : 2023-09-15 DOI: 10.7704/kjhugr.2023.0034
Jong Kyu Park
{"title":"Optimal Use of Proton Pump Inhibitors and Potassium-competitive Acid Blockers","authors":"Jong Kyu Park","doi":"10.7704/kjhugr.2023.0034","DOIUrl":"https://doi.org/10.7704/kjhugr.2023.0034","url":null,"abstract":"A variety of proton pump inhibitors (PPIs) have been developed in Korea since the introduction of omeprazole (the first PPI) in 1989. PPIs have served as the basic therapeutic approach for the management of gastric acid-related diseases for 30 years and remain among the most widely used drugs. Recently, potassium-competitive acid blockers (PCABs) have been developed both in Korea and abroad, demonstrating superior or non-inferior effects compared to existing PPIs in treating gastroesophageal reflux disease or Helicobacter pylori eradication, among others. Indications vary based on the various types and dosages of PPIs and PCABs, and several factors, including patients’ underlying disease, safety profile, particularly with regard to drug-drug interactions, and types of formulations of PPIs and PCABs need to be considered prior to prescribing these medications. In this article, we discuss the criteria for reimbursement of various PPIs and PCABs in Korea, along with considerations for prescribing these drugs based on patients’ underlying diseases.","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41965230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic Resistance and Helicobacter pylori Eradication Therapy 抗生素耐药性与幽门螺杆菌根除治疗
The Korean Journal of Helicobacter and Upper Gastrointestinal Research Pub Date : 2023-09-15 DOI: 10.7704/kjhugr.2023.0044
Y. Choe
{"title":"Antibiotic Resistance and Helicobacter pylori Eradication Therapy","authors":"Y. Choe","doi":"10.7704/kjhugr.2023.0044","DOIUrl":"https://doi.org/10.7704/kjhugr.2023.0044","url":null,"abstract":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research is an Open-Access Journal. All articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (https:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. BRIEF REPORT ISSN 1738-3331 eISSN 2671-826X, https://doi.org/10.7704/kjhugr.2023.0044 Korean J Helicobacter Up Gastrointest Res, 2023;23(3):218-221","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49321440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vonoprazan-based Dual and Triple Therapy for Helicobacter pylori Eradication Vonoprazan为基础的双重和三重疗法根除幽门螺杆菌
The Korean Journal of Helicobacter and Upper Gastrointestinal Research Pub Date : 2023-09-15 DOI: 10.7704/kjhugr.2023.0022
J. Noh, Kee Don Choi
{"title":"Vonoprazan-based Dual and Triple Therapy for Helicobacter pylori Eradication","authors":"J. Noh, Kee Don Choi","doi":"10.7704/kjhugr.2023.0022","DOIUrl":"https://doi.org/10.7704/kjhugr.2023.0022","url":null,"abstract":"Article: Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial (Gastroenterology 2022;163:608-619","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46521535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders 钾竞争酸阻滞剂在胃酸相关疾病治疗中的作用
The Korean Journal of Helicobacter and Upper Gastrointestinal Research Pub Date : 2023-09-15 DOI: 10.7704/kjhugr.2023.0043
Mun Young Cho, Y. Cho
{"title":"Role of Potassium-competitive Acid Blockers in the Treatment of Gastric Acid-related Disorders","authors":"Mun Young Cho, Y. Cho","doi":"10.7704/kjhugr.2023.0043","DOIUrl":"https://doi.org/10.7704/kjhugr.2023.0043","url":null,"abstract":"Owing to their superior pharmacokinetic and pharmacodynamic profiles, potassium-competitive acid blockers (P-CABs) score over proton pump inhibitors (PPIs) in the treatment of gastric acid-related disorders and may provide clinical benefit in the management of these conditions. Previous studies have compared P-CABs with PPIs for treatment of gastric acid-related disorders, and current data show that P-CABs are non-inferior to PPIs in the treatment of erosive esophagitis and as maintenance therapy. P-CABs are useful for effective healing and as maintenance medications in patients with severe esophagitis. These drugs also aid with healing of peptic ulcers and artificial ulcers secondary to gastric endoscopic submucosal dissection (ESD). Few studies have discussed prevention of delayed ulcer bleeding after gastric ESD and ulcers associated with long-term nonsteroidal anti-inflammatory drug administration. Well-controlled, large-scale prospective studies are warranted in future to compare P-CABs with PPIs.","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44295023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信